Roundtable Discussion; The Future of Mineral Sands. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksBr.small Co.2 Regulatory News (BSC)

Share Price Information for Br.small Co.2 (BSC)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 56.50
Bid: 55.50
Ask: 57.50
Change: 0.00 (0.00%)
Spread: 2.00 (3.604%)
Open: 56.50
High: 56.50
Low: 56.50
Prev. Close: 56.50
BSC Live PriceLast checked at -
British Smaller Companies VCT 2 is an Investment Trust

To create a portfolio that blends a mix of businesses operating in established industries with those that offer opportunities in the application and development of innovation.

Find out More

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Interim Management Statement

21 Jun 2022 15:00

RNS Number : 6747P
British Smaller Companies VCT2 Plc
21 June 2022
 

British Smaller Companies VCT2 plc

Interim Management Statement

For the quarter ended 31 March 2022

British Smaller Companies VCT2 plc (the "Company") presents its interim management statement for the quarter ended 31 March 2022. The statement also includes relevant financial information between the end of the quarter and the date of this statement. A copy of this interim management statement can be found at www.bscfunds.com.

Overview

The Company's Total Return at 31 March 2022 was unchanged at 139.5 pence per ordinary share. During the same period the FTSE Small Cap Market Overview fell by 6.8 per cent.

In the quarter the Company made one new investment, providing £2.0 million of funding to Relative Insight, a company which delivers scenario planning and forecasting solutions for supply chain, finance and operations. The investment enables the business to continue its global expansion strategy and product development. Two follow-on investments were also made in the period, into Arraco and Sipsynergy, totalling £0.5 million.

Following the quarter end one new investment and two follow-on investments totalling £1.3 million have been completed.

Performance

The movement in Total Return in pence per ordinary share is set out in the table below:

 

31 December 2021

Increase in Value

Issue/Buyback of shares

Movement

In Period

31 March 2022

Net Assets (£m)

87.4

0.6

23.5

24.1

111.5

NAV per share (PPS)

61.5p

0.3p

(0.3p)

-

61.5p

Cumulative dividends paid (PPS)

78.0p

-

-

-

78.0p

Total Return (PPS)

139.5p

0.3p

(0.3p)

-

139.5p

Shares in issue

142,155,199

-

39,041,964

39,041,964

181,197,163

The unaudited NAV per ordinary share was unchanged at 61.5 pence per share (31 December 2021: 61.5 pence per ordinary share).

The movements in NAV per ordinary share are set out in the table below:

 

 

£m

Pence per

ordinary share

NAV at 31 December 2021

87.4

61.5

Increase in portfolio value

1.0

0.6

Net operating costs

(0.4)

(0.3)

Issue/buy-back of shares

23.5

(0.3)

 

24.1

-

NAV at 31 March 2022

 

111.5

 

61.5

 

Following payment of an interim dividend of 1.5 pence per ordinary share for the year ending 31 December 2022 on 6 May 2022, the unaudited net asset value is 60.0 pence per ordinary share.

Dividends and shares in issue

On 7 January 2022, the Company issued 40,224,521 ordinary shares arising from the 2021/22 fundraising, at offer prices between 61.74 pence and 66.16 pence per ordinary share.

On 29 March 2022, the Company purchased 1,182,557 ordinary shares of 10 pence each at a price of 58.93 pence per ordinary share. These shares were placed in treasury.

The number of ordinary shares in issue at 31 March 2022 was 181,197,163 (31 December 2021: 142,155,199). In addition, at 31 March 2022 the Company held 17,112,331 ordinary shares in treasury (31 December 2021: 15,929,774)

Following payment of the first interim dividend for the year ending 31 December 2022 of 1.5 pence per ordinary share on 6 May 2022, the Company issued 903,714 ordinary shares under the DRIS, taking cumulative dividends paid to 79.5 pence per ordinary share and the number of ordinary shares in issue to 182,100,877 at that date.

Net assets

Net assets at 31 March 2022 comprised the following:

£000

% of net assets

Unquoted investments at fair value

73,569

66.0%

Cash and cash equivalents

41,721

37.4%

Other net current liabilities

(3,782)

(3.4%)

Net assets

111,508

100.0%

 

Investments

The investment portfolio at 31 March 2022 comprised:

Valuation

£000

Cumulative valuation as a % of net assets

Matillion

23,696

21.3%

Springboard Research

4,425

25.2%

Unbiased

4,153

28.9%

Wooshii

3,399

32.0%

Intelligent Office UK

3,368

35.0%

Elucidat

3,084

37.8%

SharpCloud

2,865

40.3%

Force24

2,665

42.7%

ACC Aviation

2,436

44.9%

DisplayPlan

2,366

47.0%

52,457

47.0%

Other investments

21,112

66.0%

Total investments

73,569

66.0%

Shareholder relations

We are pleased to confirm the return of an in-person Investor Workshop for 2022. This will be held jointly with British Smaller Companies VCT plc on 29 June 2022 at 1 Great George Street, Westminster, London SW1P 3AA. After the success of the webinars over the past couple of years, we will also continue providing these once per year, with the next event planned for December 2022.

Ukraine

During the build up to and subsequent to the recent invasion of Ukraine by Russia, we have been closely monitoring the impact of the war on your portfolio. There is minimal direct impact, which has principally been in a small number of cases where portfolio company software development teams have been based in Ukraine. From a business perspective, continuity of supply and service has been secured, although we are aware of a small number of developers who we believe are directly caught in the conflict and our thoughts are with them and all those suffering the humanitarian impact of the war.

Outlook

Whilst the current UK and global economic backdrop presents an overall challenging environment the search for those smaller higher growth businesses that can develop and adapt over the medium term continues with the characteristics sought unchanged. In all the businesses there will be an even greater emphasis on focussing capital on those areas delivering a shorter term impact, but we believe that the requirement and demand for equity from the UK's smaller businesses is likely to be heightened over the coming months which will give your Company opportunity to add to its portfolio.

Following the recent fundraise we are well placed to take advantage of this opportunities as they arise.

The information contained within this announcement is deemed by the Company to constitute inside information as stipulated under the Market Abuse Regulations (EU No. 596/2014). Upon the publication of this announcement via Regulatory Information Service this inside information is now considered to be in the public domain.

21 June 2022

For further information please contact:

David Hall YFM Private Equity Limited Tel: 0113 244 1000

Alex Collins Panmure Gordon (UK) Limited Tel: 0207 886 2767

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
QRFZZGZVFMDGZZM
Date   Source Headline
3rd Apr 20248:04 amRNSDirector/PDMR Shareholding
3rd Apr 20248:04 amRNSDirector/PDMR Shareholding
3rd Apr 20247:57 amRNSIssue of Equity and Close of Offers
26th Mar 202411:10 amRNSTransaction in Own Shares and Total Voting Rights
21st Mar 20247:40 amRNSAppointment of non-executive Director
20th Mar 202412:00 pmRNSPublication of Supplementary Prospectus
20th Mar 202412:00 pmRNSPublication of Supplementary Prospectus
15th Mar 202412:15 pmRNSAnnual Financial Report
16th Feb 20243:52 pmRNSClose of Offers to New Applications
16th Feb 20243:51 pmRNSClose of Offers to New Applications
30th Jan 20249:26 amRNSDirector/PDMR Shareholding
30th Jan 20249:24 amRNSDirector/PDMR Shareholding
30th Jan 20249:24 amRNSIssue of Equity
18th Dec 20234:04 pmRNSTransaction in Own Shares
13th Dec 20234:00 pmRNSOffer Update
13th Dec 20234:00 pmRNSStrategy/Company/Ops Update
24th Nov 20237:00 amRNS3rd Quarter Results
3rd Nov 20239:40 amRNSPayment of dividend and issue of equity
24th Oct 20231:20 pmRNSOffer Update
24th Oct 20231:19 pmRNSOffer Update
6th Oct 202310:19 amRNSOffer Update
6th Oct 202310:17 amRNSOffer Update
27th Sep 20238:21 amRNSOffer Update
26th Sep 20238:16 amRNSTransaction in Own Shares
20th Sep 202312:30 pmRNSPublication of a Prospectus
20th Sep 202312:30 pmRNSPublication of a Prospectus
13th Sep 20237:00 amRNSHalf-year Report
2nd Aug 202310:25 amRNSNew combined offer for subscription
2nd Aug 202310:25 amRNSNew combined offer for subscription
27th Jun 20237:46 amRNSTransaction in Own Shares
26th Jun 202310:57 amRNSDirector/PDMR Shareholding
26th Jun 202310:56 amRNSPayment of Dividend and Issue of Equity
16th Jun 202312:00 pmRNS1st Quarter Results
15th Jun 20233:17 pmRNSResult of Meeting
15th Jun 20233:16 pmRNSResult of AGM
4th Apr 20233:25 pmRNSDirector/PDMR Shareholding
4th Apr 20233:25 pmRNSDirector/PDMR Shareholding
4th Apr 20233:24 pmRNSDirector/PDMR Shareholding
4th Apr 20233:22 pmRNSIssue of Equity and Close of Offers
29th Mar 20238:40 amRNSTransaction in Own Shares
27th Mar 20236:00 pmRNSClose of Offers to new Applications
27th Mar 20236:00 pmRNSClose of Offers to new Applications
23rd Mar 202311:30 amRNSPublication of Circular
22nd Mar 202312:15 pmRNSPublication of Supplementary Prospectus
22nd Mar 202312:15 pmRNSPublication of Supplementary Prospectus
20th Mar 20233:00 pmRNSAnnual Financial Report
14th Feb 20234:35 pmRNSOffer Update
14th Feb 20234:35 pmRNSOffer Update
11th Jan 202310:00 amRNSPayment of Dividend and Issue of Equity
19th Dec 20228:50 amRNSTransaction in Own Shares

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.